GENE ONLINE|News &
Opinion
Blog

Asia-Pacific
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Australia’s Biggest Week in Life Sciences For Biotechnology Advancement
2023-11-01
Victoria Offers Grants to Accelerate mRNA-Based Therapeutics Research
2023-11-01
Global Expansion between Europe and India of Novel anti-PD-1 mAb Serplulimab
2023-10-31
Strides Pharma to Sell Manufacturing Facility in Cost Optimization Move
2023-10-31
Mithra Submits Marketing Approval Application in Japan to Combat Dysmenorrhea
2023-10-26
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons
2023-10-24
Singapore Health Tech Startup Mesh Bio Raises Funds to Tackle Chronic Diseases
2023-10-24
Innovative Magnetic Gel Offers Hope for Faster Healing of Diabetic Wounds
2023-10-23
Daiichi Sankyo Advances Care Standards with Groundbreaking Cancer Treatment
2023-10-20
Novo Nordisk Acquires Ocedurenone with $1.3B for Hypertension and Cardiovascular Disease
2023-10-18
Singapore and Japan Collaborate on Groundbreaking Robotic Telesurgery Trial
2023-10-17
The South Korean Company Revolutionizing Home-Use Medical Devices
2023-10-17
Nucleate Taiwan Launched: Pivot of International Bioindustry
2023-10-11
Kyowa Kirin to Acquire Orchard Therapeutics, Forging a Path in Genetic Medicine
2023-10-11
1 2 3 4 5 35
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top